Missing/wrong data?
Log in to edit
First-in-human Phase I study of EZN-4176, a locked nucleic acid antisense oligonucleotide to exon 4 of the androgen receptor mRNA in patients with castration-resistant prostate cancer.
scientific article published on 29 October 2013
Author/s
author: David Lorente, Mateus Crespo, Susana Miranda, Dana E. Rathkopf, Gerhardt Attard
Work details
Publication date
October 29, 2013
-
-
Language
English
Copyright status
Copyright status information is not available for this work. The copyright status depends on the jurisdiction, the author's date of death and the date the work was created or published.
To learn more about copyright terms in different countries, visit the countries and terms page.